Severity
Critical
FDA Devices recall · Reported August 15, 2018
Potential for control line not appearing on the test strip
Qiagen Sciences, Inc. recalled AmniSure ROM Test under the following labels: 1) Catalog Number FMRT-1-25 and 2) Catalog … - a critical-severity action.
AmniSure ROM Test under the following labels: 1) Catalog Number FMRT-1-25 and 2) Catalog … was recalled by Qiagen Sciences, Inc. in August 15, 2018. Reason: Potential for control line not appearing on the test strip. Check the official notice for the remedy. Verify recall #Z-2577-2018 with the FDA Devices before acting.
The recall
Qiagen Sciences, Inc. issued this critical-severity FDA Devices recall-Potential for control line not appearing on the test strip.
Sourced from official FDA Devices enforcement records. Verify recall #Z-2577-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-2577-2018) was formally reported on August 15, 2018, with the manufacturer initiating the action on May 18, 2018. It is classified under Critical severity (Class I), with a current status of Terminated. Qiagen Sciences, Inc. is listed as the recalling firm, operating out of Germantown, MD. Federal records list the affected scope as 1620 kits.
The documented reason for this recall is: Potential for control line not appearing on the test strip Distribution data in the federal record shows the product reached: Worldwide - US Nationwide distribution an in the country of , Canada. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
1620 kits
Related Recalls
6
3 from same agency
AmniSure ROM Test under the following labels: 1) Catalog Number FMRT-1-25 and 2) Catalog Number FMRT-1-25-CA Product Usage: Rapid, non-instrumented, qualitative immunochromatographic test for the in vitro detection of amniotic fluid in vaginal discharge of pregnant women.
Potential for control line not appearing on the test strip
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | Z-2577-2018 |
| Date reported | August 15, 2018 |
| Date initiated | May 18, 2018 |
| Recalling firm | Qiagen Sciences, Inc. |
| Firm location | Germantown, MD |
| Affected scope | 1620 kits |
| Distribution | Worldwide - US Nationwide distribution an in the country of , Canada |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported August 15, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.